Investor · LA JOLLA, CA

Matthew W. Foehr

Open Matthew in the network graph →

Filings

4

SEC Form D

Connections

34

co-filers

Capital

$121.4M

across filings

Active

Jan 2016

to Sep 2025

Most-connected co-filers (34)

Paul Maier · San Diego, CA1 shared Kurt L. Gustafson · Irvine, CA1 shared John L. Lamattina · Cambridge, MA1 shared Brian Lian · New York, NY1 shared Steve R. Crouse · Emeryville, CA1 shared Steve R. Love · Emeryville, CA1 shared Philip J. Gotwals · Emeryville, CA1 shared Charles W. Berkman · Emeryville, CA1 shared Jennifer W. Cochran · Emeryville, CA1 shared John W. Higgins · Emeryville, CA1 shared Kurt W. Gustafson · Emeryville, CA1 shared Carolyn R. Bertozzi · Emeryville, CA1 shared John Kozarich · Salt Lake City, UT1 shared William M. Merino · Los Angeles, CA1 shared John W. Beck · Los Angeles, CA1 shared Michael Morneau · San Diego, CA1 shared Lawson Macartney · San Diego, CA1 shared J. M. Singleton · San Diego, CA1 shared Stephen W. Webster · San Diego, CA1 shared Paul V. Maier · SAN DIEGO, CA1 shared Melanie S. Herman · LA JOLLA, CA1 shared Stephen M. Sabba · LA JOLLA, CA1 shared Charles S. Berkman · LA JOLLA, CA1 shared Jason S. Aryeh · LA JOLLA, CA1 shared

Recent filings (4)

OmniAb, Inc.Sep 2025 · 17 co-filers$30.0M OmniAb, Inc.Sep 2025 · 17 co-filers$30.0M RITTER PHARMACEUTICALS INCNov 2018 · 15 co-filers$6.0M RITTER PHARMACEUTICALS INCNov 2018 · 15 co-filers$6.0M Viking Therapeutics, Inc.Jun 2017 · 11 co-filers$3.7M Viking Therapeutics, Inc.Jun 2017 · 11 co-filers$3.7M LIGAND PHARMACEUTICALS INCJan 2016 · 23 co-filers$85.4M LIGAND PHARMACEUTICALS INCJan 2016 · 23 co-filers$85.4M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →